CD33 and neoplasm: Functioning as an inhibitory receptor expressed on NK cells, Siglec-9, another member of CD33-related Siglecs, has been demonstrated to play a negative role for reactive oxygen species (ROS) production on neutrophils to suppress anti-tumor activity [51].